MedCity News February 11, 2021
Khadijah M. Silver

In a wide-ranging interview, Maggie Huston, associate general counsel for precision medicine company Tempus, discusses how to balance innovation with safety as the FDA grapples with AI/ML and new, more complex technology, as well how her company quickly reacted to Covid-19.

Most in-house attorneys start their careers elsewhere and then end up on the corporate side.

Not Maggie Huston, who is an associate general counsel for Tempus, the precision medicine startup based in Chicago. Huston has spent her entire career in-house at healthtech companies, thereby witnessing the industry’s transformation over her 10-year career. That includes a stint as corporate counsel for Epic during the national implementation of meaningful use.

In a wide-ranging conversation, Huston addressed many topics including how Tempus...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: AI (Artificial Intelligence), Biotechnology, FDA, Govt Agencies, Interview / Q&A, Pharma / Biotech, Precision Medicine, Technology, Trends
Exploring the potential of personalized precision medicine for healthcare industry
Putting Patients First by Extending the Reach of World-Class Care
Healthcare's most promising tech
AI In Healthcare: A New Era Of Personalized Patient Care
23andMe reports sales decline a day after announcing plans to cut 40% of workforce

Share This Article